Your browser doesn't support javascript.
loading
Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin.
Schutt, Carolyn; Ibsen, Stuart; Zahavy, Eran; Aryal, Santosh; Kuo, Stacey; Esener, Selin; Berns, Michael; Esener, Sadik.
Afiliación
  • Schutt C; Department of Bioengineering, University of California San Diego, 9500 Gilman Dr. MC 0412, La Jolla, California, 92093-0412, USA. carolyn.schutt@gmail.com.
  • Ibsen S; Moores Cancer Center, University of California San Diego, La Jolla, California, 92093, USA.
  • Zahavy E; Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, P.O. Box 19, 74100, Ness-Ziona, Israel.
  • Aryal S; Department of Chemistry, Nanotechnology Innovation Center of Kansas State, Kansas State University, Manhattan, Kansas, 66506, USA.
  • Kuo S; Department of Nanoengineering, University of California San Diego, La Jolla, California, 92093, USA.
  • Esener S; Department of Nanoengineering, University of California San Diego, La Jolla, California, 92093, USA.
  • Berns M; Department of Bioengineering, University of California San Diego, 9500 Gilman Dr. MC 0412, La Jolla, California, 92093-0412, USA.
  • Esener S; Department of Nanoengineering, University of California San Diego, La Jolla, California, 92093, USA.
Pharm Res ; 34(10): 2025-2035, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28791550

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Portadores de Fármacos / Profármacos / Doxorrubicina / Nanopartículas / Antineoplásicos Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Portadores de Fármacos / Profármacos / Doxorrubicina / Nanopartículas / Antineoplásicos Límite: Humans Idioma: En Año: 2017 Tipo del documento: Article